This groundbreaking discovery led to a new mGluR-based theory of FXS, which states that dysregulated mGluR1/5-mediated protein synthesis-dependent forms of synaptic plasticity contribute to the pathology of FXS (Bear et al., 2004). The gene discussed is GRM1; the disease is fragile X syndrome.